SCHEDULE 13G/A: OT Healthcare Fund I Discloses 8.1% Stake in Adagene Inc.

OT Healthcare Fund I, along with its affiliates OT Management, LLC and Nichola Eliovits, has disclosed a beneficial ownership of 8.1% in Adagene Inc.'s ordinary shares.

Summary

• OT Healthcare Fund I, LLC, OT Management, LLC, and Nichola Eliovits have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Adagene Inc.
• The filing indicates beneficial ownership of 3,567,653 American Depositary Receipts (ADRs), which represent 4,459,566 ordinary shares of Adagene Inc.
• This aggregate amount represents 8.1% of Adagene Inc.'s class of ordinary shares.
• OT Management, LLC and Nichola Eliovits each hold sole voting and sole dispositive power over the 3,567,653 ADRs.
• The securities were not acquired or held for the purpose of changing or influencing the control of Adagene Inc., other than activities solely in connection with a nomination under Rule 240.14a-11.

Sentiment

Score: 5

Explanation: This is an informational filing regarding beneficial ownership and does not inherently convey positive or negative sentiment about the company's performance or prospects.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of significant ownership by an investment fund in a publicly traded company, common in the financial industry. It does not provide broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant ownership stake held by an investment fund, which can influence market perception and trading activity.

Key Dates

Keywords

Adagene Inc., OT Healthcare Fund I, Schedule 13G, Beneficial Ownership, Ordinary Shares, ADRs, SEC Filing, Investment, Biotechnology